TACSTD2 and exocrine pancreatic carcinoma: TROP2, originally identified in human trophoblast and choriocarcinoma cells, which was highly expressed in many cancers include pancreatic carcinoma [10], gastric carcinoma [8], lung carcinoma [12] and colorectal cancer [11].